Last month, the FDA authorized the sale of 10 Zyn flavors, marking the first time the agency has backed the public health ...

Cannabis pouches emerge as an alternative to smoking, but can they match Zyn's success? Experts weigh in on market potential ...

Tobacco harm reduction advocates in the Philippines lauded the U.S. Food and Drug Administration’s marketing authorizations ...

Nicotine pouches have become a multibillion-dollar industry. Now Cannadips and other brands are putting their money where ...

Cigarette giant Philip Morris International on Thursday forecast better-than-expected profit growth for 2025, with ...

The U.S. Food and Drug Administration (FDA) has authorized the marketing of Zyn nicotine pouches as a reduced-risk ...

Philip Morris International posted higher-than-expected revenue in its fourth quarter as its Zyn nicotine pouches continued ...

New York lawmakers are pushing to ban flavored nicotine pouches like Zyn, citing concerns they appeal to minors.

While investors in the tobacco space have tended to be more focused on dividends over the years, Philip Morris International ...

Philip Morris International Inc.’s stock touched a record high on Thursday after the company issued a profit outlook that ...

Philip Morris is a leading dividend business with strong smoke-free product growth, including IQOS and ZYN. Read why PM stock ...

Jacek Olczak, Philip Morris International CEO, joins CNBC's 'Money Movers' to discuss the company's most recent earnings.